Denise M. Harnois

Dr. Denise M. Harnois


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2010 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
CPC. Panjala
C. Panjala
DSD. L. Senecal
D. L. Senecal
MBM D Bridges
M D Bridges
GKG. P. Kim
G. P. Kim
RNR. E. Nakhleh
R. E. Nakhleh
DHDenise M. Harnois
Denise M. Harnois
Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare primary liver malignancy with mixed hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) histological features. It is almost impossible to obtain an accurate, preoperative noninvasive diagnosis of cHCC-CC with tumor markers or cross-sectional abdominal imaging due to the mixed histological features. Despite these difficulties, accurate cHCC-CC diagnosis remains an important goal with prognostic significance. In our study, we retrospectively reviewed the tumor markers: AFP and CA 19-9, and cross-sectional liver imaging, in light of liver explant findings, to identify and characterize cHCC-CC features followed by liver transplantation (LT) outcome analysis. The results from this 12 patient cohort failed to identify characteristic features for cHCC-CC. None of the imaging features helped to identify the cHCC-CC tumor and they mimicked either HCC or CC, depending on the degree of glandular differentiation expressed histologically. In our cHCC-CC LT recipients, the 1-, 3- and 5-year cumulative survival probabilities were 79%, 66% and 16%, respectively with a 5-year survival comparable to or better than LT for intrahepatic CC but poorer than LT for HCC following the Milan criteria. Conceivably explained by its cholangiocarcinoma component the LT outcome for this rare and hard to diagnose tumor appears poor.

12 July 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
DZDaoshan Zheng
Daoshan Zheng
JTJustyna Trynda
Justyna Trynda
Cecilia WilliamsCecilia Williams
Cecilia Williams
JVJeremy A. Vold
Jeremy A. Vold
JNJustin H. Nguyen
Justin H. Nguyen
ZLZhaoyu Li
Zhaoyu Li
Sex differences in the incidences of cancers become a critical issue in both cancer research and the development of precision medicine. However, details in these differences have not been well reported. We provide a comprehensive analysis of sexual dimorphism in human cancers. We analyzed four sets of cancer incidence data from the SEER (USA, 1975–2015), from the Cancer Registry at Mayo Clinic (1970–2015), from Sweden (1970–2015), and from the World Cancer Report in 2012. We found that all human cancers had statistically significant sexual dimorphism with male dominance in the United States and mostly significant in the Mayo Clinic, Sweden, and the world data, except for thyroid cancer, which is female-dominant. Sexual dimorphism is a clear but mostly neglected phenotype for most human cancers regarding the clinical practice of cancer. We expect that our study will facilitate the mechanistic studies of sexual dimorphism in human cancers. We believe that fully addressing the mechanisms of sexual dimorphism in human cancers will greatly benefit current development of individualized precision medicine beginning from the sex-specific diagnosis, prognosis, and treatment.

11 September 2015 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
MEMohamed A. Elfeki
Mohamed A. Elfeki
SPSurakit Pungpapong
Surakit Pungpapong
PGPetrina V. Genco
Petrina V. Genco
RNRaouf E. Nakhleh
Raouf E. Nakhleh
JNJustin H. Nguyen
Justin H. Nguyen
DHDenise M. Harnois
Denise M. Harnois

20 July 2019 in Liver Transplantation
Verified
Journal Article
Closed access
OMOmar Y. Mousa
Omar Y. Mousa
JNJustin H. Nguyen
Justin H. Nguyen
YMYaohua Ma
Yaohua Ma
BRBhupendra Rawal
Bhupendra Rawal
KMKaitlyn R. Musto
Kaitlyn R. Musto
DHDenise M. Harnois
Denise M. Harnois

5 December 2011 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
CPChakri Panjala
Chakri Panjala
JNJustin H. Nguyen
Justin H. Nguyen
AAAli N. Al-Hajjaj
Ali N. Al-Hajjaj
BRBarry A. Rosser
Barry A. Rosser
RNRaouf E. Nakhleh
Raouf E. Nakhleh
DHDenise M. Harnois
Denise M. Harnois

3 June 2020 in Journal of Gastrointestinal and Liver Diseases
Verified
Journal Article
Open access
PDF file
KWKarn Wijarnpreecha
Karn Wijarnpreecha
PPPanadeekarn Panjawatanan
Panadeekarn Panjawatanan
Wisit CheungpasitpornWisit Cheungpasitporn
Wisit Cheungpasitporn
FLFrank J Lukens
Frank J Lukens
DHDenise M. Harnois
Denise M. Harnois
PUPatompong Ungprasert
Patompong Ungprasert
Background and Aims: Recent studies have suggested an association between periodontitis and nonalcoholic fatty liver disease (NAFLD) although the results were inconsistent. The current systematic review and meta- analysis was conducted with the aim to comprehensively investigate this possible association by identifying all relevant studies and combining their results together. Methods: A comprehensive literature review was conducted utilizing the MEDLINE and EMBASE databases through December 2019 to identify all studies that compared the risk of NAFLD among patients with periodontitis to individuals without periodontitis. Effect estimates from each study were extracted and combined using the random-effect, generic inverse variance method of DerSimonian and Laird. Results: A total of five studies with 27,703 participants fulfilled the eligibility criteria and were included in the meta-analysis. All five studies reported the magnitude of association between NAFLD and periodontitis that was diagnosed based on the periodontal pocket depth of > 3.5-4 mm. The pooled OR of unadjusted analysis was 1.48 (95%CI: 1.15-1.89; I 2 92%). However, when adjusted results from the primary studies were used, pooled OR decreased to 1.13 and lost its statistical significance (95%CI: 0.95–1.35; I 2 67%). Three studies reported the magnitude of association between NAFLD and periodontitis that was diagnosed based on a clinical attachment level of ≥ 3 mm. The pooled OR of unadjusted analysis was 1.13 (95%CI: 1.07-1.20; I 2 0%). However, when adjusted results from the primary studied were used, pooled OR decreased to 1.08 and lost its statistical significance (95%CI: 0.94–1.24; I 2 58%). Conclusions: The study found a significant association between periodontitis and NAFLD. However, the association lost its significance when various metabolic parameters were adjusted, suggesting that those metabolic conditions, not periodontitis itself, were predisposing factors for NAFLD.